Cardiovascular Medicine Grand Rounds are Fridays from 8:00 am - 9:00 am in the ACTRI Building Conf. Room 1W-210. Due to recent COVID-19 restrictions, Grand Rounds will be held virtually. Please contact
Margo Relaford for questions or to be added to our email list.
Upcoming Grand Rounds
October 15, 2021
"Improving risk assessment and streamlining the management of atrial fibrillation: Easy as ABC..."
Gregory YH Lip, MD, FRCP (London Edinburgh Glasgow), DFM, AFHEA, FESC, FEHRA
Price-Evans Chair of Cardiovascular Medicine,
University of Liverpool, United Kingdom;
Distinguished Professor, Faculty of Medicine,
Aalborg University, Denmark;
Adjunct Professor, Yonsei Univesrsity of, Seoul, South Koreal;
Adjunct Professor, Seoul National University, South Koreal
2020-2021
January 29, 2021
"Cardiac Amyloidosis: The Future is Now"
Ahmad Masri, MD, MS
Director, Hypertrophic Cardiomyopathy Center
Assistant Professor of Medicine
Oregon Health and Science University
February 5, 2021
"Rate or Rhythm Control in Atrial Fibrillation: Why? When? How?"
Vivek Reddy, MD
Helmsley Trust Professor of Medicine Director,
Cardiac Electrophysiology Mount Sinai School of Medicine
February 9, 2021
"Demystifying the Tricuspid Valve: Anatomy, Pathophysiology and Treatment"
Rebecca T. Hahn, MD, FACC, FESC, FASE
Professor of Medicine, Columbia University Medical Center
February 26, 2021
"The Ischemia Trial, an updated look at stable ischemic heart disease"
Kevin Ting, MD & Antoinette Birs, MD
Cardiovascular Medicine Fellows,
University of California, San Diego
March 5, 2021
"Medical Decision Making in Heart Failure: Engaging Patients"
Larry Allen, MD, MHS
Professor of Medicine, University of Colorado
March 12, 2021
"Hypertrophic Cardiomyopathy in 2021 and Beyond"
Carolyn Ho MD
Medical Director, Cardiovascular Genetics Center, Brigham and Women's Hospital
March 19, 2021
"PARA-Gone with the Wind? Finding significance in a “negative” trial"
Patrick Azcarate, MD & Omid Behnamfar, MD
Cardiovascular Medicine Fellows,
University of California, San Diego
April 2, 2021
"Clinical Innovation and the Management of Cardiac Arrhythmias"
William Sauer, MD
Section Chief Cardiac Arrhythmia Service
Brigham and Women’s Hospital
Harvard Medical School
April 9, 2021
"Cardiorenal Effects of SGLT2 Inhibitors: A New Tool in the Cardiologist Toolbox"
Darren K. McGuire, MD, MHSc
Distinguished Teaching Professor of Medicine
University of Texas Southwestern Medical Center
Parkland Health and Hospital System
Dallas, TX
April 16, 2021
"Heart Failure with mildly reduced and Normal Ejection Fraction"
Scott D. Solomon, MD,
The Edward D. Frohlich Distinguished Chair,
Professor of Medicine, Harvard Medical School,
Brigham and Women’s Hospital
April 23, 2021
"Autonomic Nervous System and Cardiac Arrhythmia"
Peng-Sheng Chen,MD
Editor-in-Chief,Heart Rhythm Journal
Burns&Allen Chair in Cardiology Research
Staff Physician III
Department of Cardiology, Smidt Heart Institute
Cedars-Sinai Medical Center
April 30, 2021
"The Endothelium in Health and Disease"
John Keaney, MD
Chief, Division of Cardiovascular Medicine
Brigham and Women’s Hospital
Victor J. Dzau Professor of Medicine
Harvard Medical School
May 7, 2021
"Surgical and interventional therapeutics for CTEPH: History and UCSD's experience"
"Methamphetamine Associated Heart Failure (MethHC): A Unique UCSD Experience"
Abdullah Almasoud, MD & Marin Nishimura, MD
Cardiovascular Medicine Fellows
University of California, San Diego
May 10, 2021
"Surgical and interventional therapeutics for CTEPH: History and UCSD's experience"
"Contemporary updates on venoarterial extracorporeal membrane oxygenation"
Jason Duran, MD, PhD & Danuiel Mangels, MD
Cardiovascular Medicine Fellows
University of California, San Diego
May 14, 2021
"Clinical Staging in Hypertrophic Cardiomyopathy: Approach to Risk Stratification and Management"
Jorge Silva Enciso, MD
Assocaite Clinical Professor of Medicine
Director, Hypertrophic Cardiomyopathy Program
Heart Failure, Mechanical Circulatory Support and Trasplant Cardiology
May 28, 2021
"STEMI: Cardioprotection durting Mycardial Reperfusion" Dr. Govea
"Subclinical CVD and Primary Prevention: My Year in the T32" Dr. Bhatia
Alayn Govea, MD & Harpreet Bhatia, MD Cardiovascular Medicine Fellows
University of California, San Diego
September 17, 2021
"Finding the Vulnerable Plaque to Prevent Heart Attack"
David Erlinge, MD. PhD, FESC, FACC
Department Head of Cardiology
Lund University, Sweden
September 24, 2021
"DoReMi Trial: Music to our ears? Or a cacophony ifof sound?"
Antoinette Birs, MD & Anoop Muniyappa, MDCardiovascular Medicine Fellows
University of California, San Diego
October 1, 2021
"Anitplatlet Therapy After PCI: An overview of the Latest Evidence"
Roxana Mehran, MD, FACC, FAHA, MSCAI, RESC
Professor of Medicine in Cardiology and Population Health Science and Policy
Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes
Director of Interventional Cardiovascular Research and Clinical Trials
October 8, 2021
"Update on Omega-3 Fatty Acids"
Deepak Bhatt , MD, MPH Executive Director of Interventional Cardiovascular Programs
Brigham and Women's Hospital Heart & Vascular Center
Professor of Medicine, Harvard Medical School